Local recurrence of Prostate Cancer: a scoring system using multiparametric magnetic resonance imaging

Congress:

ECR 2020

Poster Number:

C-11563

Type:

Scientific Exhibit

Keywords:

Neoplasia, Contrast agent-intravenous, MR-Diffusion/Perfusion, MR, Oncology, Genital / Reproductive system male, Genitourinary, Prospective, Observational, Performed at one institution

Authors:

S. cipollari¹, G. Anello¹, F. Giganti², M. Pecoraro¹, D. Fierro¹, R. Campa³, M. Del Monte¹, C. Catalano¹, V. Panebianco¹; ¹rome/IT, ²London/UK, ³Roma/IT

DOI:

10.26044/ecr2020/C-11563

DOI-Link:

https://dx.doi.org/10.26044/ecr2020/C-11563

Purpose

Despite radical treatment for clinically localized Prostate Cancer (PCa) with curative intent, early recurrence occurs between 27% and 53% of all men undergoing prostatectomy (RP) or radiotherapy (RT) [1]. In this background, the aim of the study wast o propose a standardized multiparametric magnetic resonance imaging (mpMRI) method for the acquisition, interpretation and reporting of prostate cancer (PCa) local recurrence diagnosis after radical prostatectomy (RP) and develop assessment categories that summarize levels of local recurrence suspicion.